In fact studies into animal models of arthritis have shown that combining an IDO inhibitor with either methotrexate (MTX) or B-cell depletion therapy was more effective in alleviating arthritis compared with either treatment alone [94, 95]. This evidence concerns the gene IDO1 and arthritic joint disease.